Thermo Fisher Scientific Announces $2 Billion Investment to Strengthen U.S. Manufacturing and Innovation

On April 24, in Waltham, Massachusetts, Thermo Fisher Scientific, the world leader in scientific services, announced an additional $2 billion investment in the United States over the next four years to strengthen innovation, manufacturing, and economic competitiveness in the life sciences sector.

As one of the largest pharmaceutical manufacturers in the world, Thermo Fisher Scientific enables biopharmaceutical companies to develop and produce drugs in the United States. These additional investments in the company's U.S. manufacturing capabilities support a resilient U.S. healthcare supply chain and will generate a strong multiplier effect across the U.S. economy.

The $20 billion investment over the next four years includes:

$1.5 billion in capital expenditures to strengthen and expand manufacturing operations in the United States

Supported by $500 million in R&D, focused on high-impact innovations

Marc N. Casper, Chairman, President, and Chief Executive Officer of Thermo Fisher Scientific Inc., stated:"Thermo Fisher Scientific's commitment to U.S. manufacturing reflects our confidence that the United States will continue to lead the world in science and innovation. Thermo Fisher Scientific is proud to be an engine of growth for the U.S. economy. By expanding our operations in the United States, we ensure that life-saving drugs and therapies will continue to be developed and manufactured in the U.S. for decades to come."

This investment builds on Thermo Fisher Scientific's industry-leading foundation in U.S. manufacturing and innovation. The company operates 64 manufacturing facilities across 37 states in the U.S., producing analytical instruments, specialty diagnostics, and life science solutions, while also providing contract development and manufacturing services for pharmaceutical innovators.

Since 2017, Thermo Fisher Scientific’s scale has more than doubled, increasing from $21 billion in revenue and 28,000 U.S. employees to $43 billion, with over 50,000 U.S. employees today. The company invests $1 billion annually in R&D within the United States. Over the next four years, Thermo Fisher Scientific will continue to expand its presence in the U.S. by creating high-paying jobs, enhancing manufacturing and laboratory service capabilities, and investing in R&D.

Follow the official account below to see the world!